Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Naloxone Costs Could Temper Non-Rx Access Even As Distribution Spreads

Executive Summary

CVS in 31 states offers naloxone from pharmacists without a prescription and Walgreens offers it in 14, with plans to more than double the program this year. Whether from pharmacists or OTC, "an affordable price is essential if this is to reach the people who need it," says harm reduction advocate Scott Burris.

Advertisement

Related Content

Bring Naloxone To Opioid Overdoses: FDA Crowd-Sources Smartphone Apps
Opioid Abuse: White House Expanding Access To Buprenorphine, Naloxone
Light Still On For Switches After Pfizer Pulls Plug On OTC Lipitor
Naloxone Switch: Door Opener For Other NDAs That Swing On Consumer Education
FDA Ponders Drug Pricing In Opioid Abuse Analysis

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

PS118994

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel